According to Morphosys's latest financial reports the company has $0.75 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.75 B | -22.31% |
2022-12-31 | $0.97 B | -13.66% |
2021-12-31 | $1.12 B | -16.09% |
2020-12-31 | $1.34 B | 339.31% |
2019-12-31 | $0.30 B | -25.66% |
2018-12-31 | $0.41 B | 111.12% |
2017-12-31 | $0.19 B | 27.37% |
2016-12-31 | $0.15 B | -26.09% |
2015-12-31 | $0.20 B | 16.09% |
2014-12-31 | $0.17 B | -52.67% |
2013-12-31 | $0.37 B | 134.18% |
2012-12-31 | $0.16 B | -8.45% |
2011-12-31 | $0.17 B | 198.91% |
2010-12-31 | $58.68 M | -0.72% |
2009-12-31 | $59.1 M | 5.4% |
2008-12-31 | $56.07 M | -20.66% |
2007-12-31 | $70.67 M | 1320.14% |
2006-12-31 | $4.97 M | 4.85% |
2005-12-31 | $4.74 M | -72.07% |
2004-12-31 | $16.99 M | 102.96% |
2003-12-31 | $8.37 M | 817.33% |
2002-12-31 | $0.91 M |